Pro-glucagon derived peptide therapies for type 2 diabetes and obesity
Pro-glucagon derived peptides, namely glucagon like peptide-l (GLP- I), oxyntomodulin, glucagon and the structurally related peptide, glucose dependent insulinotropic polypeptide (GIP) work to maintain glucose homeostasis, energy balance and body weight. In diabetes the action of GIP is attenuated a...
| Main Author: | |
|---|---|
| Published: |
Ulster University
2014
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.669694 |